These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19714675)

  • 1. Synthesis and pharmacological evaluation of thiazole and isothiazole derived apomorphines.
    Sipos A; Mueller FK; Lehmann J; Berényi S; Antus S
    Arch Pharm (Weinheim); 2009 Oct; 342(10):557-68. PubMed ID: 19714675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-substituted apomorphines as potent dopamine agonists.
    Reinart-Okugbeni R; Vonk A; Uustare A; Gyulai Z; Sipos A; Rinken A
    Bioorg Med Chem; 2013 Jul; 21(14):4143-50. PubMed ID: 23727194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.
    Herm L; Berényi S; Vonk A; Rinken A; Sipos A
    Bioorg Med Chem; 2009 Jul; 17(13):4756-62. PubMed ID: 19454369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 2-thioether-substituted apomorphines as potent and selective dopamine D₂ receptor agonists.
    Reinart R; Gyulai Z; Berényi S; Antus S; Vonk A; Rinken A; Sipos A
    Eur J Med Chem; 2011 Jul; 46(7):2992-9. PubMed ID: 21550699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine/serotonin receptor ligands. 16.(1) Expanding dibenz[d,g]azecines to 11- and 12-membered homologues. Interaction with dopamine D(1)-D(5) receptors.
    Enzensperger C; Müller FK; Schmalwasser B; Wiecha P; Traber H; Lehmann J
    J Med Chem; 2007 Sep; 50(18):4528-33. PubMed ID: 17676831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and neuropharmacological characterization of 2-O-substituted apomorphines.
    Sipos A; Csutorás C; Berényi S; Uustare A; Rinken A
    Bioorg Med Chem; 2008 Apr; 16(8):4563-8. PubMed ID: 18313931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of hemantane on the main subtypes of dopamine receptors in the rat striatum ex vivo].
    Abaimov DA; Zimin IA; Kovalev GI
    Eksp Klin Farmakol; 2008; 71(1):18-21. PubMed ID: 18365481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
    Hackling A; Ghosh R; Perachon S; Mann A; Höltje HD; Wermuth CG; Schwartz JC; Sippl W; Sokoloff P; Stark H
    J Med Chem; 2003 Aug; 46(18):3883-99. PubMed ID: 12930150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylpiperazinylmethylheterocycle derivatives: synthesis and dopamine receptor binding profiles.
    Abadi AH
    Arch Pharm (Weinheim); 2004 Jul; 337(7):383-90. PubMed ID: 15237388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ring expansions of tetrahydroprotoberberines and related dibenzo[c,g]azecines modulate the dopamine receptor subtype affinity and selectivity.
    Schulze M; Siol O; Meise W; Lehmann J; Enzensperger C
    Arch Pharm (Weinheim); 2010 Apr; 343(4):207-14. PubMed ID: 20222063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.
    Elsner J; Boeckler F; Heinemann FW; Hübner H; Gmeiner P
    J Med Chem; 2005 Sep; 48(18):5771-9. PubMed ID: 16134944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of functional roles of DRY motif in the 2nd intracellular loop of dopamine D2 and D3 receptors.
    Kim JH; Cho EY; Min C; Park JH; Kim KM
    Arch Pharm Res; 2008 Apr; 31(4):474-81. PubMed ID: 18449505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological investigation of novel 2-aminothiazole-privileged aporphines.
    Liu Z; Chen X; Yu L; Zhen X; Zhang A
    Bioorg Med Chem; 2008 Jul; 16(14):6675-81. PubMed ID: 18562201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and functional activity of (2-aryl-1-piperazinyl)-N-(3-methylphenyl)acetamides: selective dopamine D4 receptor agonists.
    Matulenko MA; Hakeem AA; Kolasa T; Nakane M; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem; 2004 Jul; 12(13):3471-83. PubMed ID: 15186832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor agonist potencies for inhibition of cell firing correlate with dopamine D3 receptor binding affinities.
    Kreiss DS; Bergstrom DA; Gonzalez AM; Huang KX; Sibley DR; Walters JR
    Eur J Pharmacol; 1995 Apr; 277(2-3):209-14. PubMed ID: 7493610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and binding studies of 2-arylapomorphines.
    Søndergaard K; Kristensen JL; Palner M; Gillings N; Knudsen GM; Roth BL; Begtrup M
    Org Biomol Chem; 2005 Nov; 3(22):4077-81. PubMed ID: 16267586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues.
    Gao YG; Baldessarini RJ; Kula NS; Neumeyer JL
    J Med Chem; 1990 Jun; 33(6):1800-5. PubMed ID: 1971309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.